Compare Aurora Cannabis Inc (ACB) vs Seagate Technology Holdings PLC (STX) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

STX trades at $827.64, up 0.91% today, with a bearish technical signal and neutral oscillators. The stock shows strong fundamental momentum, with Q1 2026 EPS of $4.10 beating expectations of $3.51, continuing a trend of earnings beats. Revenue for 2025 reached $9.10 billion with a net income margin of 21.6%, while valuation ratios like P/E of 82.38 and P/B of 179.4 reflect high growth expectations. Recent news highlights STX as a top momentum stock amid AI-driven demand, despite sector volatility.

The outlook for STX is positive, driven by robust earnings growth and AI infrastructure demand, with a consensus price target of $955.71 implying 15% upside. Risks include high debt levels, with a debt-to-asset ratio of 73.31% in 2024, and sensitivity to memory market fluctuations, as seen in recent sell-offs. Investor sentiment remains bullish among analysts, with 51% buy ratings, but technical weakness warrants caution near-term.